QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-monopar-therapeutics-maintains-2-price-target

HC Wainwright & Co. analyst Sean Lee reiterates Monopar Therapeutics (NASDAQ:MNPR) with a Buy and maintains $2 price tar...

 monopar-therapeutics-q1-2024-gaap-eps-010-beats-014-estimate

Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of ...

 monopar-announces-radiopharma-presentation-selected-for-society-of-nuclear-medicine-and-molecular-imaging-2024-annual-meeting

Monopar Therapeutics Inc. (NASDAQ:MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments...

 monopar-announces-filing-of-patent-protecting-mnpr-101-radiopharma-optimization-findings

Monopar Therapeutics Inc. (NASDAQ:MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments...

 jonestrading-upgrades-monopar-therapeutics-to-buy-announces-2-price-target

JonesTrading analyst Soumit Roy upgrades Monopar Therapeutics (NASDAQ:MNPR) from Hold to Buy and announces $2 price target.

 monopar-therapeutics-q4-gaap-eps-012-beats-015-estimate

Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of ...

 why-peraso-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected four...

 monopar-therapeutics-says-nasdaq-has-granted-co-180-day-extension-to-aug-26-to-regain-compliance

-SEC Filing

 monopar-therapeutics-provides-update-on-mnpr-101-zr-radiopharma-clinical-trial-8k

Rradiopharmaceutical physician, Professor Rodney Hicks, will be the lead investigator for Monopar's MNPR-101-Zr Phase 1 dos...

 crude-oil-down-2-maravai-lifesciences-shares-spike-higher

U.S. stocks traded mostly higher midway through trading, with the Dow Jones index jumping more than 100 points on Friday. The ...

 dow-surges-over-150-points-aercap-posts-upbeat-earnings

U.S. stocks traded higher this morning, with the Dow Jones index jumping more than 150 points on Friday.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION